Concepedia

Sylvie Ducki

SD

Statistics

Publications

42

Citations

2.6K

H-Index

26

Active since

1995

Affiliations

University of Salford(Current)

Université Clermont Auvergne

Centre National de la Recherche Scientifique

Clermont-Ferrand’s Superior National School of Chemistry

University of Manchester

Sylvie Ducki is an author at University of Salford specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

1995–2020

42

Publications

42

Potent antimitotic and cell growth inhibitory properties of substituted chalcones

Sylvie Ducki, Richard Forrest, John A. Hadfield et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 367 citations · Full text

, , +10

Tubulin and microtubules as targets for anticancer drugs.

John A. Hadfield, Sylvie Ducki, Nicholas Hirst et al. · PubMed · 2003 · 247 citations

, , +12

Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: Synthesis and biological evaluation of antivascular activity

Sylvie Ducki, David Rennison, Meiko Woo et al. · Bioorganic & Medicinal Chemistry · 2009 · 189 citations · Full text

, , +14

1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin

Kristin Odlo, Jean Hentzen, Jérémie Fournier Dit Chabert et al. · Bioorganic & Medicinal Chemistry · 2008 · 179 citations · Full text

, , +13

Effects of α-substitutions on structure and biological activity of anticancer chalcones

Nicholas J. Lawrence, Richard P. Patterson, Li‐Ling Ooi et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 150 citations

, , +11

1–5 of 42